Whan In Pharm Co.,Ltd. (KRX: 016580)

Market Cap	186.26B
Revenue (ttm)	251.73B
Net Income (ttm)	27.36B
Shares Out	15.27M
EPS (ttm)	1,792.04
PE Ratio	6.81
Forward PE	9.24
Dividend	300.00 (2.44%)
Ex-Dividend Date	n/a

Volume	17,793
Open	12,170
Previous Close	12,220
Day's Range	12,030 - 12,500
52-Week Range	12,030 - 15,900
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Whan In Pharm Co.,Ltd.

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 582
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 016580

Financial Performance

In 2023, Whan In Pharm Co.,Ltd.'s revenue was 230.39 billion, an increase of 15.81% compared to the previous year's 198.93 billion. Earnings were 29.77 billion, an increase of 24.47%.